B

BrightGene

China - Suzhou
Biotechnology

Focus: APIS, Small Molecules

BrightGene is a life sciences company focused on APIS, Small Molecules.

Infectious Diseases
Open Jobs
0
Interview Prep Quick Facts
Founded: 2022
Portfolio: 2 approved products, 15 clinical trials
Top TAs: Metabolic Diseases, Infectious Diseases
Portfolio Health
Post-LOE2 (100%)
2 total products
Therapeutic Area Focus
Marketed
Pipeline